Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 11:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1801–1824 of 2,761 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: Cerebral Palsy
Interventions: Prone and Upright Locomotor Training; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 6 Weeks
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Infection, Human Immunodeficiency Virus, HIV Infections
Interventions: CAB Oral Tablets, CAB LA, ABC/3TC Oral tablets, RPV Oral Tablets, HAART, RPV; Drug · Other
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 309 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2023
U.S. locations: 15
States / cities: Birmingham, Alabama • Bakersfield, California • Beverly Hills, California + 12 more

Conditions: HIV Infections
Interventions: ALVAC(2)120(B,MN)GNP (vCP1452), Aldesleukin; Biological · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 19 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2006
U.S. locations: 1
States / cities: New York, New York

Conditions: Low Back Pain
Interventions: Soft Tissue, Myofascial release, Counterstrain, Muscle energy, Sacro-iliac articulation, High-velocity, low amplitude; Procedure
Lead sponsor: University of North Texas Health Science Center; Other
Eligibility: 17 Years to 35 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Fort Lewis, Washington

Conditions: Neuromuscular Disease, Motor Neuron Disease, Inherited Neuromuscular Conditions, Inherited Neuropathies
Interventions: EIM testing, Nerve & muscle ultrasonography, Nerve conduction studies, Electromyography (EMG); Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 2 Years to 110 Years
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Shingles, Vaccination Behavior, Behavior, Health
Interventions: Reminder; Behavioral
Lead sponsor: Geisinger Clinic; Other
Eligibility: 50 Years and older
Enrollment: 50,786 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Danville, Pennsylvania

Conditions: HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD), Arterial Inflammation, Heart Disease
Interventions: Eplerenone, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 40 Years to 80 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 2
States / cities: Los Angeles, California • Boston, Massachusetts

Conditions: Sleep Disturbance, Sleep, Depression, Suicide
Interventions: TranS-C, Sleep Feedback; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 12 Years to 18 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Lung Diseases, Asthma
Interventions: Counseling, Urine Cotinine Feedback, Contingent Incentives, Usual education program; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 8 Years to 13 Years
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: San Diego, California

Conditions: Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease, Hypoxemia
Interventions: Portable Oxygen Concentrator, Portable compressed oxygen D-tanks, No ambulatory oxygen therapy; Device · Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Athletes in Cutting Sports
Interventions: Ankle tape, Standard lace-up ankle brace, Standard high ankle-sprain (HAS) brace, Low-profile HAS brace, No ankle brace or tape; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 40 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Cystic Fibrosis
Interventions: Placebo Respimat, Tiotropium bromide 5 mcg, tiotropium bromide-low dose-2.5mcg; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: Not listed
Enrollment: 510 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 26
States / cities: Tucson, Arizona • San Diego, California • Jacksonville, Florida + 20 more

Conditions: DNA Methylation
Interventions: Exercise; Behavioral
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 30 Years to 45 Years · Female only
Enrollment: 276 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Transcranial Direct Current Stimulation
Interventions: Active Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS); Device
Lead sponsor: United States Army Aeromedical Research Laboratory; Federal
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Fort Rucker, Alabama

Conditions: Cardiovascular Risk Factor, Lipemia
Interventions: High-fat meal; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: COPD
Interventions: Breath Responsive Variable Bolus Oxygen Conserving Device; Device
Lead sponsor: StratiHealth; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 3
States / cities: Oceanside, California • Vista, California • Westminster, California

Conditions: Chronic Graft-versus-host-disease
Interventions: Axatilimab; Drug
Lead sponsor: Syndax Pharmaceuticals; Industry
Eligibility: 2 Years and older
Enrollment: 296 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 47
States / cities: Birmingham, Alabama • Duarte, California • Los Angeles, California + 37 more

Conditions: Teen Pregnancy Prevention
Interventions: Teens Exploring and Managing Prevention Options (TEMPO); Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 13 Years to 19 Years
Enrollment: 447 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Colitis, Ulcerative
Interventions: Low-dose MH002, High-dose MH002, Placebo; Drug
Lead sponsor: MRM Health NV; Industry
Eligibility: 16 Years and older
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 6
States / cities: Miami, Florida • Orlando, Florida • Palmetto Bay, Florida + 3 more

Conditions: High Intensity Focused Ultrasound, Deep Brain Stimulation
Interventions: Behavioral Assessment; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 85 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Knee Osteoarthritis
Interventions: High-speed power training, Slow-speed strength training; Other
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 55 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Anxiety, Memory, Epilepsy
Interventions: CAMERA (Context-Aware Multimodal Ecological Research and Assessment); Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple Sclerosis
Interventions: Blood sample collection for coagulation profile; Diagnostic Test
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Cervical Dystonia
Interventions: DaxibotulinumtoxinA for injection, Placebo; Biological
Lead sponsor: Revance Therapeutics, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 44
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Fountain Valley, California + 38 more

Search by objective public record fields.

Locomotor Learning in Infants at High Risk for Cerebral Palsy

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load

How Does Manual Therapy Improve Low Back Pain for Soldiers?

Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers

Nudging Patients to Increase Shingles Vaccination

Reducing Arterial Inflammation Using Eplerenone and Statins in HIV

Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)

Environmental Tobacco Smoke Exposure Reduction in High-Risk Preteens

Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia

Enovis High Ankle Sprain Brace Testing

Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis

DNA Methylation and Cancer Prevention: Duration and Intensity of Exercise

Sustaining Aviator Performance During Extended Operational Flight

Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1

A Prospective Observational Study of the Breath Responsive Variable Bolus Oxygen Conserving Device

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

Brief Intervention for Teen Pregnancy Prevention

Confirmatory Clinical Study in Active Ulcerative Colitis

Interactions of Brain Regions in Visuomotor Adaptation

High-speed Power Training in Older Adults With Knee Osteoarthritis (OA)

Prediction of Anxiety and Memory State

VALIDATE: Factor VIII Trending for MS Relapse

Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)